The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-100
SponsorUniversity of Nicosia

About this trial

Parkinson's disease is a chronic, neurodegenerative disease of unknown cause, affecting elderly people over the age of 60. It is the second most common neurodegenerative disease, presenting psychomotor signs and symptoms that lead to impaired functionality and quality of life in affected individuals. Mixed reality involves the delivery of digital stimuli in real time and space through spatial mapping using glasses, safely providing multiple iterations to carry out daily activities.

Through this tool and in collaboration with technologically skilled mixed reality developers, the software for the rehabilitation program to be applied to Parkinson's disease patients was also developed.

The main objective of this clinical study is to examine the effect of a mixed reality program compared to a traditional physiotherapy program on quality of life and motivation for the participation of people with Parkinson's disease.

Eligibility criteria

Qualifiers

None

Disqualifiers

Presence of neurological disease

Presence of uncontrolled diseases of the circulatory system

History of musculoskeletal surgery in the last 6 months

Use of a walking aid

Trial design

Treatments tested in this trial

  • Mixed Reality
  • Traditional Physiotherapy

Treatment groups

15 Participants
are divided into 3 treatment groups

Sponsors and collaborators